International legal practice Osborne Clarke has advised Novo Nordisk on a major commercial lease agreement for Carré-Michelet Tower, a restructured/refurbished, high-quality and HQE/BREEAM labelized, office tower in Paris La Defense business district.
Under the agreement, NovoNordisk, a global healthcare company with more than 95 years of innovation and leadership in diabetes care, will occupy approx. 3,300 sq.m in the Tower.
Carré-Michelet Tower is a 9 storey, 34,000 sq.m development by Gecina. Located in the southeast part of the business district of La Défense, the Tower has undergone a major restructuring carried out by Eiffage.
This rehabilitation has enabled:
- 35% increase in the surface area by raising the building with the construction of 7 upper levels on the circular boulevard and 3 other sides of the courtyard, thus adding an additional 10,000 sq.m to the total floor area;
- the separation of two adjoining volumes, highlighting its square shape;
- the renovation of the 7 existing floors;
- the expansion of work spaces with approx. 2,700 sq.m trays.
The architecture of the building has been completely redesigned by the agency Crochon Brullmann & Associés, associated with the agency Architecture et Environnement. A 2,300 m² glass facade, signed by Goyer, a subsidiary of Eiffage specializing in the design and implementation of aluminum and glass facades, replaced the original sloping glass to homogenize the silhouette of the building.
Osborne Clarke is a recognised industry leader in real estate providing a comprehensive sector-led service that provide responsive advice to a variety of major real estate industry organisations, ranging from developers and investors to property funds and corporate occupiers.